TM2-5 Percutaneous electrical nerve stimulation (PENS) therapy for refractory primary headache disorders: a pilot study

Autor: MW Weatherall, Dipankar Nandi

Publikováno v: Journal of Neurology, Neurosurgery & Psychiatry. 90:e14.1-e14

ObjectivesPrimary headache disorders are common, but many patients are refractory to medical treatment. PENS therapy involves the stimulation of one or more individual nerves or dermatomes using needle probes. We assessed whether a ‘single shot wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::60d5901f8aabcbde6022570a4ca1d1b5
https://doi.org/10.1136/jnnp-2019-abn.43

Clinical outcome analysis of patients with multiple sclerosis - Analysis from the UK Medical Cannabis Registry.

Autor: Murphy M; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK., Kaur V; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK., Bui HL; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK., Yang T; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK., Erridge S; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK; Curaleaf Clinic, London, UK., Holvey C; Curaleaf Clinic, London, UK., Coomber R; Curaleaf Clinic, London, UK; St. George's Hospital NHS Trust, London, UK., Rucker JJ; Curaleaf Clinic, London, UK; Department of Psychological Medicine, Kings College London, London, UK; South London & Maudsley NHS Foundation Trust, London, UK., Weatherall MW; Curaleaf Clinic, London, UK; Buckinghamshire Healthcare NHS Trust, Amersham, UK., Sodergren MH; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK; Curaleaf Clinic, London, UK. Electronic address: m.sodergren@imperial.ac.uk.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Jul; Vol. 87, pp. 105665. Date of Electronic Publication: 2024 May 06.

UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia.

Autor: Vivek K; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK., Karagozlu Z; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK., Erridge S; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Medicine, Curaleaf Clinic, London, UK., Holvey C; Department of Medicine, Curaleaf Clinic, London, UK., Coomber R; Department of Medicine, Curaleaf Clinic, London, UK.; Department of Trauma and Orthopaedics, St. George's Hospital NHS Trust, London, UK., Rucker JJ; Department of Medicine, Curaleaf Clinic, London, UK.; Department of Psychological Medicine, Kings College London, London, UK.; National and Specialist Tertiary Referrals Affective Disorders Service, South London & Maudsley NHS Foundation Trust, London, UK., Weatherall MW; Department of Medicine, Curaleaf Clinic, London, UK.; Department of Neurology, Buckinghamshire Healthcare NHS Trust, Amersham, UK., Sodergren MH; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Medicine, Curaleaf Clinic, London, UK.

Publikováno v: Brain and behavior [Brain Behav] 2024 Feb; Vol. 14 (2), pp. e3410.

An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry.

Autor: Ergisi M; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Erridge S; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Sapphire Medical Clinics, London, United Kingdom., Harris M; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Kawka M; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Nimalan D; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Salazar O; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Loupasaki K; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Ali R; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Holvey C; Sapphire Medical Clinics, London, United Kingdom., Coomber R; Sapphire Medical Clinics, London, United Kingdom.; St. George's Hospital NHS Trust, London, United Kingdom., Usmani A; Sapphire Medical Clinics, London, United Kingdom.; Dartford and Gravesham NHS Trust, Kent, United Kingdom., Sajad M; Sapphire Medical Clinics, London, United Kingdom.; Dudley Group of Hospitals NHS Trust, West Midlands, United Kingdom., Beri S; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Sapphire Medical Clinics, London, United Kingdom., Hoare J; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Sapphire Medical Clinics, London, United Kingdom., Khan SA; Sapphire Medical Clinics, London, United Kingdom.; Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Weatherall MW; Sapphire Medical Clinics, London, United Kingdom.; Buckinghamshire Healthcare NHS Trust, Amersham, United Kingdom., Platt M; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Sapphire Medical Clinics, London, United Kingdom., Rucker JJ; Sapphire Medical Clinics, London, United Kingdom.; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, United Kingdom.; South London and Maudsley NHS Foundation Trust, London, United Kingdom., Sodergren MH; Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Sapphire Medical Clinics, London, United Kingdom.

Publikováno v: Cannabis and cannabinoid research [Cannabis Cannabinoid Res] 2023 Jun; Vol. 8 (3), pp. 557-566. Date of Electronic Publication: 2022 Jan 24.

An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry.

Autor: Olsson F; Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK., Erridge S; Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Medicine, Sapphire Medical Clinics, London, UK., Tait J; Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Medicine, Sapphire Medical Clinics, London, UK., Holvey C; Department of Medicine, Sapphire Medical Clinics, London, UK., Coomber R; Department of Medicine, Sapphire Medical Clinics, London, UK.; Department of Trauma & Orthopaedics, St. George's Hospital NHS Trust, London, UK., Beri S; Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Medicine, Sapphire Medical Clinics, London, UK., Hoare J; Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Medicine, Sapphire Medical Clinics, London, UK., Khan S; Department of Medicine, Sapphire Medical Clinics, London, UK.; Department of Palliative Medicine, Guy's & St. Thomas' NHS Foundation Trust, London, UK., Weatherall MW; Department of Medicine, Sapphire Medical Clinics, London, UK.; Department of Neurology, Buckinghamshire Healthcare NHS Trust, Amersham, UK., Platt M; Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Medicine, Sapphire Medical Clinics, London, UK., Rucker JJ; Department of Medicine, Sapphire Medical Clinics, London, UK.; Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; Centre for Affective Disorders, South London & Maudsley NHS Foundation Trust, London, UK., Sodergren MH; Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Medicine, Sapphire Medical Clinics, London, UK.

Publikováno v: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2023 Mar; Vol. 16 (3), pp. 257-266. Date of Electronic Publication: 2023 Mar 03.